Adding interferon-α to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours: Abstracted from: Kölby L, Persson G, Franzén S, Ahrén B, Randomized clinical trial of the effect of interferon-α on survival in patients with disseminated midgut carcinoid tumours. British Journal of Surgery 2003; 90: 687–693.

✍ Scribed by Ulrich-Frank Pape; Bertram Wiedenmann

• Book ID: 116394849
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 95 KB
• Volume: 29
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2003.07.002